Clinical Trials Logo

Binge-Eating Disorder clinical trials

View clinical trials related to Binge-Eating Disorder.

Filter by:

NCT ID: NCT03540641 Completed - Clinical trials for Binge-Eating Disorder

Transcranial Magnetic Stimulation (TMS) in Binge Eating Disorder (BED)

TMS&BED
Start date: April 6, 2017
Phase: N/A
Study type: Interventional

This study evaluates de efficacy of 5Hz repetitive Transcranial Magnetic Stimulation (rTMS) applied on the left dorsolateral prefrontal cortex in patients with binge eating disorder.

NCT ID: NCT03539900 Completed - Clinical trials for Binge-Eating Disorder

Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder

Start date: April 17, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

This study will test the efficacy of naltrexone HCI and bupropion HCI (NB) versus placebo in patients with binge-eating disorder (BED), with or without obesity.

NCT ID: NCT03531112 Terminated - Weight Loss Clinical Trials

Reducing Binge Eating to Prevent Weight Gain in Black Women

Start date: January 12, 2019
Phase: N/A
Study type: Interventional

The purpose of the proposed study is to pilot a 6-month, cognitive-behavioral binge eating intervention, Appetite Awareness Training (AAT) to reduce binge eating and prevent weight gain for Black women with a BMI > 25 kg/m^2 and with weekly binge eating episodes. Intervention participants will receive a 8-week group AAT intervention, and will also receive bluetooth-connected scales for daily weighing. Participants will also receive tailored feedback on self-weighing frequency and weight change. The investigators will follow-up with participants at six months.

NCT ID: NCT03429114 Completed - Binge Eating Clinical Trials

Emotion Regulation in Binge Eating and Purging Among Adolescents

Start date: October 15, 2017
Phase:
Study type: Observational

The study will examine the neural and behavioral correlates of emotion regulation in adolescents engaging in binge eating and/or purging and healthy adolescents. Furthermore, it will look at the influence of executive function on emotion regulation in this population. This study will allow us to gain further understanding of the neural basis of emotion regulation in this age group. Moreover, this study supports the need to develop new treatment approaches based on a better understanding of the brain processes associated with eating disorders.

NCT ID: NCT03404713 Terminated - Clinical trials for Overweight and Obesity

Evaluating the Feasibility of a Stepped-care Approach to Treating Adolescents With Binge and Loss of Control Eating

Start date: February 15, 2018
Phase: N/A
Study type: Interventional

There are limited evidence-based treatments for adolescents with binge eating and fewer specifically targeting adolescents with both binge eating and overweight/obesity. The existing research for adolescents with overweight/obesity and loss of control (LOC) eating supports a stepped-care model of treatment in which enhanced behavioral weight loss treatment is the first line of treatment followed by more intensive therapeutic treatment for individuals with remaining emotional eating difficulties. Thus, in this proposed study, the investigators will systematically develop a stepped-care protocol and manualized interventions for adolescents with LOC and binge eating behaviors. The investigators will then evaluate the feasibility and acceptability of the interventions in a pilot trial and gather preliminary outcome data to inform development of a subsequent randomized controlled trial.

NCT ID: NCT03393039 Recruiting - Obesity Clinical Trials

Effects of Negative Affect in Individuals With Binge Eating Episodes

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

Binge-eating is characterized by recurrent episodes of eating large amounts of - typically high calorie - foods, eating much more rapidly than normal and until feeling uncomfortably full, as well as feeling disgusted with oneself, depressed, or guilty after those episodes. Two eating disorders are characterized by binge-eating as central diagnostic criteria, binge-eating disorder (BED) and bulimia nervosa (BN). Binge-eating episodes in BN, but not BED, are typically followed by compensatory mechanisms such as self-induced vomiting, and BED is typically associated with obesity, while BN is not. Behavior studies such as ecological momentary assessment (EMA) research of affect in an individual's naturalistic environment have shown that negative affect and negative urgency (the tendency to act rashly when distressed) often precede binge-eating. The Investigators want to answer the following questions: Can negative affect in BN and BED be linked to 1) altered dopamine related brain reinforcement learning, 2) to food value computation and cognitive control circuit function, and 3) can dopamine related brain activation predict eating and negative affect, indicating a brain based neurobiological vulnerability. Answering those questions will help to define binge-eating based on regulation of brain reward, cognition, and emotion circuit function and point toward potential psychopharmacological interventions to normalize brain function and behavior.

NCT ID: NCT03353649 Completed - Behavior Clinical Trials

Applying Novel Technologies and Methods to Inform the Ontology of Self-Regulation: Binge Eating and Smoking

Start date: December 8, 2017
Phase: N/A
Study type: Interventional

This study aims to examine targets of self-regulatory function among two exemplar populations for which behavior plays a critical role in health outcomes: smokers and individual who binge eat (BED). This is the second phase of a study that aims to identify putative mechanisms of behavior change to develop an overarching "ontology" of self-regulatory processes.

NCT ID: NCT03352713 Completed - Smoking Clinical Trials

Using Mobile Technology to Better Understand and Measure Self-Regulation

Start date: January 11, 2018
Phase: N/A
Study type: Interventional

This study will evaluate the extent to which we can engage and manipulate putative targets within the self-regulation domain outside of laboratory settings in samples of smokers and overweight/obese individuals with binge eating disorder. Fifty smokers and 50 overweight/obese individuals with binge eating disorder will be recruited to participate in a non-lab experimental paradigm in which we will leverage our novel mobile behavioral assessment/intervention technology platform. We will measure and modulate engagement of potential self-regulation targets and collect data in real time and in real-world conditions. Mobile sensing will be added to up to 50 additional participants.

NCT ID: NCT03348475 Completed - Clinical trials for Binge-Eating Disorder

Binge Focused Therapy: A Guided, Self-help, Group-based Approach for Binge Eating Disorder

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

The "Brain Over Binge Recovery Guide" (Hansen, 2016), is a self-help approach that incorporates fundamental aspects of Acceptance and Commitment Therapy, Dialectical Behavioural Therapy, Motivational Enhancement Therapy and addictions treatment. This approach has been streamlined into a guided self-help protocol (Binge Focused Therapy, or BFT) that can be delivered by undergraduate students with minimal mental health experience in 3 group sessions spread over 8 weeks (i.e., Week 1, Week 2, Week 8). The aim of this proof-of-concept study is to provide preliminary data to examine whether this approach is feasible and has clinical potential for patients with binge eating disorder.

NCT ID: NCT03317379 Completed - Anorexia Nervosa Clinical Trials

Evaluation of the Communities of Healing Mentorship/Support Group Program: Assessment of Preliminary Efficacy

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

The goal of the study is to evaluate two 6-month adjunct interventions (peer mentorship and social support mentorship) for individuals with eating disorders. Individuals will be randomized to peer-mentorship, social support mentorship, or a wait-list and eating disorder symptoms will be evaluated at baseline and post-treatment.